Bevacizumab in Advanced High Grade Serous Ovarian Cancer: The Impact of BRCA Mutation Status. Journal of Cancer Research Updates, [S. l.], v. 15, n. 1, p. 1–10, 2026. DOI: 10.30683/1929-2279.2026.15.01. Disponível em: https://www.neoplasiaresearch.com/index.php/jcru/article/view/928. Acesso em: 19 jun. 2026.